+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mono Vaccine Market 2022-2026

  • PDF Icon

    Report

  • 120 Pages
  • October 2022
  • Region: Global
  • TechNavio
  • ID: 5681424
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the mono vaccine market and it is poised to grow by $2.8 bn during 2022-2026, accelerating at a CAGR of 5.16% during the forecast period. This report on the mono vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

This report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in pediatric population, initiatives from government agencies, and recent drug approvals and product innovations.

The mono vaccine market analysis includes the type segment and geographic landscape.

The publisher's mono vaccine market is segmented as below:

By Type

  • Meningococcal vaccine
  • Japanese encephalitis vaccine
  • Hepatitis vaccine
  • Yellow fever vaccine
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increase in mergers and acquisitions (M&A) as one of the prime reasons driving the mono vaccine market growth during the next few years. Also, advancements in vaccine delivery systems and increasing research on combination therapies will lead to sizable demand in the market.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report on mono vaccine market covers the following areas:
  • Mono vaccine market sizing
  • Mono vaccine market forecast
  • Mono vaccine market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mono vaccine market vendors that include AstraZeneca Plc, Aurobindo Pharma Ltd., Bavarian Nordic AS, China National Pharmaceutical Group Corp., Dynavax Technologies Corp., GlaxoSmithKline Plc, Johnson and Johnson, Merck and Co. Inc., Moderna Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Valneva SE, and VBI Vaccines Inc. Also, the mono vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
  • Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
5.1 Market segments
  • Exhibit 24: Chart on Type - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
  • Exhibit 26: Chart on Comparison by Type
  • Exhibit 27: Data Table on Comparison by Type
5.3 Meningococcal Vaccine - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Meningococcal Vaccine - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Meningococcal Vaccine - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Meningococcal Vaccine - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Meningococcal Vaccine - Year-over-year growth 2021-2026 (%)
5.4 Japanese Encephalitis Vaccine - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Japanese Encephalitis Vaccine - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Japanese Encephalitis Vaccine - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Japanese Encephalitis Vaccine - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Japanese Encephalitis Vaccine - Year-over-year growth 2021-2026 (%)
5.5 Hepatitis Vaccine - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Hepatitis Vaccine - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Hepatitis Vaccine - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Hepatitis Vaccine - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Hepatitis Vaccine - Year-over-year growth 2021-2026 (%)
5.6 Yellow Fever Vaccine - Market size and forecast 2021-2026
  • Exhibit 40: Chart on Yellow Fever Vaccine - Market size and forecast 2021-2026 ($ million)
  • Exhibit 41: Data Table on Yellow Fever Vaccine - Market size and forecast 2021-2026 ($ million)
  • Exhibit 42: Chart on Yellow Fever Vaccine - Year-over-year growth 2021-2026 (%)
  • Exhibit 43: Data Table on Yellow Fever Vaccine - Year-over-year growth 2021-2026 (%)
5.7 Others - Market size and forecast 2021-2026
  • Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.8 Market opportunity by Type
  • Exhibit 48: Market opportunity by Type ($ million)
6 Customer Landscape
6.1 Customer landscape overview
  • Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
  • Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
  • Exhibit 52: Chart on Geographic comparison
  • Exhibit 53: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
  • Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
  • Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
  • Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 France - Market size and forecast 2021-2026
  • Exhibit 82: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 83: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 84: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibit 85: Data Table on France - Year-over-year growth 2021-2026 (%)
7.11 China - Market size and forecast 2021-2026
  • Exhibit 86: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 87: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 88: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 89: Data Table on China - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
  • Exhibit 90: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
  • Exhibit 91: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
  • Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
  • Exhibit 93: Overview on factors of disruption
9.4 Industry risks
  • Exhibit 94: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
  • Exhibit 95: Vendors covered
10.2 Market positioning of vendors
  • Exhibit 96: Matrix on vendor position and classification
10.3 AstraZeneca Plc
  • Exhibit 97: AstraZeneca Plc - Overview
  • Exhibit 98: AstraZeneca Plc - Product/Service
  • Exhibit 99: AstraZeneca Plc - Key news
  • Exhibit 100: AstraZeneca Plc - Key offerings
10.4 China National Pharmaceutical Group Corp.
  • Exhibit 101: China National Pharmaceutical Group Corp. - Overview
  • Exhibit 102: China National Pharmaceutical Group Corp. - Product/Service
  • Exhibit 103: China National Pharmaceutical Group Corp. - Key offerings
10.5 Dynavax Technologies Corp.
  • Exhibit 104: Dynavax Technologies Corp. - Overview
  • Exhibit 105: Dynavax Technologies Corp. - Product/Service
  • Exhibit 106: Dynavax Technologies Corp. - Key news
  • Exhibit 107: Dynavax Technologies Corp. - Key offerings
10.6 GlaxoSmithKline Plc
  • Exhibit 108: GlaxoSmithKline Plc - Overview
  • Exhibit 109: GlaxoSmithKline Plc - Business segments
  • Exhibit 110: GlaxoSmithKline Plc - Key offerings
  • Exhibit 111: GlaxoSmithKline Plc - Segment focus
10.7 Merck and Co. Inc.
  • Exhibit 112: Merck and Co. Inc. - Overview
  • Exhibit 113: Merck and Co. Inc. - Business segments
  • Exhibit 114: Merck and Co. Inc. - Key news
  • Exhibit 115: Merck and Co. Inc. - Key offerings
  • Exhibit 116: Merck and Co. Inc. - Segment focus
10.8 Moderna Inc.
  • Exhibit 117: Moderna Inc. - Overview
  • Exhibit 118: Moderna Inc. - Business segments
  • Exhibit 119: Moderna Inc. - Key offerings
  • Exhibit 120: Moderna Inc. - Segment focus
10.9 Pfizer Inc.
  • Exhibit 121: Pfizer Inc. - Overview
  • Exhibit 122: Pfizer Inc. - Product/Service
  • Exhibit 123: Pfizer Inc. - Key news
  • Exhibit 124: Pfizer Inc. - Key offerings
10.10 Sanofi SA
  • Exhibit 125: Sanofi SA - Overview
  • Exhibit 126: Sanofi SA - Business segments
  • Exhibit 127: Sanofi SA - Key news
  • Exhibit 128: Sanofi SA - Key offerings
  • Exhibit 129: Sanofi SA - Segment focus
10.11 Serum Institute of India Pvt. Ltd.
  • Exhibit 130: Serum Institute of India Pvt. Ltd. - Overview
  • Exhibit 131: Serum Institute of India Pvt. Ltd. - Product/Service
  • Exhibit 132: Serum Institute of India Pvt. Ltd. - Key offerings
10.12 Shenzhen Kangtai Biological Products Co. Ltd.
  • Exhibit 133: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
  • Exhibit 134: Shenzhen Kangtai Biological Products Co. Ltd. - Product/Service
  • Exhibit 135: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
  • Exhibit 136: Inclusions checklist
  • Exhibit 137: Exclusions checklist
11.3 Currency conversion rates for US$
  • Exhibit 138: Currency conversion rates for US$
11.4 Research methodology
  • Exhibit 139: Research methodology
  • Exhibit 140: Validation techniques employed for market sizing
  • Exhibit 141: Information sources
11.5 List of abbreviations
  • Exhibit 142: List of abbreviations
Exhibits:
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Incremental Growth
Exhibit 7: Executive Summary - Data Table on Incremental Growth
Exhibit 8: Executive Summary - Chart on Vendor Market Positioning
Exhibit 9: Parent market
Exhibit 10: Market Characteristics
Exhibit 11: Offerings of vendors included in the market definition
Exhibit 12: Market segments
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
Exhibit 28: Chart on Meningococcal Vaccine - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Meningococcal Vaccine - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Meningococcal Vaccine - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Meningococcal Vaccine - Year-over-year growth 2021-2026 (%)
Exhibit 32: Chart on Japanese Encephalitis Vaccine - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Japanese Encephalitis Vaccine - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Japanese Encephalitis Vaccine - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Japanese Encephalitis Vaccine - Year-over-year growth 2021-2026 (%)
Exhibit 36: Chart on Hepatitis Vaccine - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Hepatitis Vaccine - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Hepatitis Vaccine - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Hepatitis Vaccine - Year-over-year growth 2021-2026 (%)
Exhibit 40: Chart on Yellow Fever Vaccine - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Yellow Fever Vaccine - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Yellow Fever Vaccine - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Yellow Fever Vaccine - Year-over-year growth 2021-2026 (%)
Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibit 48: Market opportunity by Type ($ million)
Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 52: Chart on Geographic comparison
Exhibit 53: Data Table on Geographic comparison
Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibit 82: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibit 86: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 87: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 88: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 89: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibit 90: Market opportunity By Geographical Landscape ($ million)
Exhibit 91: Impact of drivers and challenges in 2021 and 2026
Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
Exhibit 93: Overview on factors of disruption
Exhibit 94: Impact of key risks on business
Exhibit 95: Vendors covered
Exhibit 96: Matrix on vendor position and classification
Exhibit 97: AstraZeneca Plc - Overview
Exhibit 98: AstraZeneca Plc - Product/Service
Exhibit 99: AstraZeneca Plc - Key news
Exhibit 100: AstraZeneca Plc - Key offerings
Exhibit 101: China National Pharmaceutical Group Corp. - Overview
Exhibit 102: China National Pharmaceutical Group Corp. - Product/Service
Exhibit 103: China National Pharmaceutical Group Corp. - Key offerings
Exhibit 104: Dynavax Technologies Corp. - Overview
Exhibit 105: Dynavax Technologies Corp. - Product/Service
Exhibit 106: Dynavax Technologies Corp. - Key news
Exhibit 107: Dynavax Technologies Corp. - Key offerings
Exhibit 108: GlaxoSmithKline Plc - Overview
Exhibit 109: GlaxoSmithKline Plc - Business segments
Exhibit 110: GlaxoSmithKline Plc - Key offerings
Exhibit 111: GlaxoSmithKline Plc - Segment focus
Exhibit 112: Merck and Co. Inc. - Overview
Exhibit 113: Merck and Co. Inc. - Business segments
Exhibit 114: Merck and Co. Inc. - Key news
Exhibit 115: Merck and Co. Inc. - Key offerings
Exhibit 116: Merck and Co. Inc. - Segment focus
Exhibit 117: Moderna Inc. - Overview
Exhibit 118: Moderna Inc. - Business segments
Exhibit 119: Moderna Inc. - Key offerings
Exhibit 120: Moderna Inc. - Segment focus
Exhibit 121: Pfizer Inc. - Overview
Exhibit 122: Pfizer Inc. - Product/Service
Exhibit 123: Pfizer Inc. - Key news
Exhibit 124: Pfizer Inc. - Key offerings
Exhibit 125: Sanofi SA - Overview
Exhibit 126: Sanofi SA - Business segments
Exhibit 127: Sanofi SA - Key news
Exhibit 128: Sanofi SA - Key offerings
Exhibit 129: Sanofi SA - Segment focus
Exhibit 130: Serum Institute of India Pvt. Ltd. - Overview
Exhibit 131: Serum Institute of India Pvt. Ltd. - Product/Service
Exhibit 132: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibit 133: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
Exhibit 134: Shenzhen Kangtai Biological Products Co. Ltd. - Product/Service
Exhibit 135: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
Exhibit 136: Inclusions checklist
Exhibit 137: Exclusions checklist
Exhibit 138: Currency conversion rates for US$
Exhibit 139: Research methodology
Exhibit 140: Validation techniques employed for market sizing
Exhibit 141: Information sources
Exhibit 142: List of abbreviations

Executive Summary

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes the publisher's platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AstraZeneca Plc
  • Aurobindo Pharma Ltd.
  • Bavarian Nordic AS
  • China National Pharmaceutical Group Corp.
  • Dynavax Technologies Corp.
  • GlaxoSmithKline Plc
  • Johnson and Johnson
  • Merck and Co. Inc.
  • Moderna Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co. Ltd.
  • Valneva SE
  • VBI Vaccines Inc.